Alkermes, Inc. investor investigation over possible securities laws violations
email@example.com 2010-10-25 16:19:15 - Investigation on behalf of investors of Alkermes, Inc. (NASDAQ:ALKS) over possible securities laws violations – ALKS stockholders should contact the Shareholders Foundation at firstname.lastname@example.org
After Alkermes, Inc. lost more than 30% in stock value an investigation on behalf of investors in Alkermes, Inc. (NASDAQ:ALKS) shares concerning potential violations of Federal Securities laws in connection with the New Drug Application for Alkermes’s diabetes drug BYDUREON was announced.
If you are an investor in shares of Alkermes, Inc. (NASDAQ:ALKS), and/or have any information relating to the investigation,
you have certain options and you should contact the Shareholders Foundation at email@example.com or call +1(858) 779 - 1554.
The investigation by a law firm on behalf of investors in ALKS shares concerns whether Alkermes, Inc., certain of its officers, directors or insiders potentially violated any Securities laws in connection with the recent developments surrounding the diabetes drug BYDUREON (TM) (exenatide extended-release for injectable suspension.